CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-04). The draft was written by AI, the existence of all 3 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2161 · Search date 2026-08-04 · Methodology v0.6

Curcumin plus piperine,
does it really help with Increased single-dose peak serum curcumin and systemic exposure?

30-Second Summary
C
Evidence Grade C · 46 · Safety caution
The early trial reported AUC of 0.004 alone and about 0.08 microgram-hours/mL with piperine, but an independent trial did not replicate benefit
Concentrated piperine can alter drug metabolism and blood exposure, so people taking prescription medicines should seek professional advice. The trial's 20 mg dose is not equivalent to ordinary culinary pepper.
What the
research shows
The grade is C with 46 points. Ten healthy men entered a randomized crossover study and eight were analyzed. Peak serum curcumin was 0.006±0.005 micrograms/mL alone and 0.18±0.16 micrograms/mL with piperine; the plus-or-minus values are standard errors. In an independent 2025 crossover trial, unconjugated curcumin stayed below quantification in both conditions and total curcumin exposure was lower with piperine, so the early signal was not independently replicated.
What the
ads claim
The 2,000% claim, calculated from AUC of 0.004 alone and about 0.08 microgram-hours/mL with piperine, is often framed as though clinical benefit were twenty-fold larger. The source trial measured only an eight-person serum curve, and culinary pepper is not equivalent to 20 mg concentrated piperine.
*

Useful facts when choosing a product

  • The capsules contained pure curcumin 2 g and pure piperine 20 mg; culinary turmeric and pepper amounts were not tested.
  • The HPLC detection limit was 0.001 micrograms/mL; Cmax was 0.006±0.005 micrograms/mL alone and 0.18±0.16 micrograms/mL with piperine, with both plus-or-minus values reported as standard errors.
  • AUC alone was 0.004 microgram-hours/mL; the reported 2,000% relative bioavailability implies about 0.08 with piperine, whose absolute AUC and confidence interval were not directly printed.
  • Cmax occurred at one hour alone and 0.75 hour with piperine, and serum concentrations reached zero by three hours.
Gap Measurement · Verdict 2161 · C 46
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Shoba et al. recruited ten healthy men and analyzed eight after comparing pure curcumin 2 g alone with pure curcumin 2 g plus piperine 20 mg in capsules two weeks apart. Affiliations were the Department of Pharmacology, St John's Medical College, Bangalore, and SAMI Chemicals & Extracts (P) Ltd., Bangalore. Majeed, Rajendran, and Srinivas were manufacturer employees; that company supplied the compounds and made the capsules, and there was no separate funding section. Kroon et al. independently tested nine healthy men in 2025 and found no piperine benefit for unconjugated or total curcumin exposure. More absorption and better health are different questions. The Delecroix clinical-outcome trial analyzed ten of sixteen participants and used curcumin 2 g plus piperine 20 mg three times daily during two four-day phases separated by a fifteen-day washout. One sprint result favored supplementation, but broader recovery did not clearly improve.

02

Why this is classified as C (46)

A randomized human crossover trial confirmed higher peak concentration and early exposure, but it analyzed only eight participants after one dose, was manufacturer-linked, and did not establish clinical outcomes, giving C with 46 points.

Counterpoint. Piperine can alter the metabolism and exposure of other drugs, so increased absorption is not automatically beneficial for people taking prescriptions.

Rejudgment record. Cross-check applied — An eight-participant randomized crossover study increased serum curcumin Cmax and early exposure, but the evidence was acute and manufacturer-linked and did not directly establish clinical outcomes

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI0Evidence comes only from manufacturer studies
Effect sizeE+Meets the clinically important threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Increased single-dose serum curcumin exposure with piperine 20 mgCCmax and early concentrations increased in an eight-participant crossover study.
Improved overall exercise recovery solely because absorption increased?A separate tiny trial had only selected positive results and did not establish an absorption-to-benefit link.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Randomized single-dose crossover pharmacokinetic study8Three SAMI Chemicals authors; company supplied compounds and capsules; no separate funding sectionSerum curcumin Cmax and AUC over zero to six hoursCmax 0.006±0.005 to 0.18±0.16 micrograms/mL, with standard errors; AUC 0.004 alone and about 0.08 with piperineCore direct absorption evidence
Study 2Randomized crossover exercise-recovery trial10No financial support reported; product supplied by MGD NaturePostexercise strength, sprint, jump, soreness, and creatine kinaseCurcumin 2 g plus piperine 20 mg three times daily in two four-day phases with a fifteen-day washout; only selected sprint results favored supplementationContext separating absorption from clinical benefit
Study 3Independent randomized crossover pharmacokinetic study9Independent of the 1998 manufacturer-linked trialUnconjugated and total curcumin Cmax, AUC, and TmaxUnconjugated curcumin below 2 nM in both conditions; total AUC 897 to 524 nM-hours and Cmax 44 to 35 nMIndependent nonreplication evidence
§

Receipt — 3 References

All 3 cited sources were verified for existence at the original page (as of 2026-08-04).

Shoba G, Joy D, Joseph T, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64(4):353-356. PMID: 9619120. DOI: 10.1055/s-2006-957450.
checked
Delecroix B, Abaïdia AE, Leduc C, Dawson B, Dupont G. Curcumin and Piperine Supplementation and Recovery Following Exercise Induced Muscle Damage: A Randomized Controlled Trial. J Sports Sci Med. 2017;16(1):147-153. PMID: 28344463. PMCID: PMC5358025.
checked
Kroon MAGM, van Laarhoven HWM, Swart EL, van Tellingen O, Kemper EM. iScience. 2025;28(6):112575. PMID: 40487425. DOI: 10.1016/j.isci.2025.112575.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-04 · Corrections: none

Cite this verdict

Curcumin plus piperine x increased blood curcumin exposure Evidence Grade C card
[Chamgap] Curcumin plus piperine x increased blood curcumin exposure — Evidence Grade C·46. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/general/curcumin-piperine-bioavailability/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.